$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq

$icdiq Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000153702822000043 Filed on August 04, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$49.15M	$42.31M	$34.99M
YoY Change	104.48%	113.52%	125.14%
Cost Of Revenue	$31.38M	$28.90M	$27.17M
YoY Change	55.94%	69.62%	86.83%
Gross Profit	$17.77M	$13.41M	$7.826M
YoY Change	354.19%	382.86%	682.6%
Gross Profit Margin	36.15%	31.69%	22.37%
Selling, General & Admin	$7.007M	$4.860M	$5.228M
YoY Change	72.25%	19.26%	41.83%
% of Gross Profit	39.44%	36.24%	66.8%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.12M	$9.848M	$9.751M
YoY Change	3.91%	3.5%	-2.39%
% of Gross Profit	56.96%	73.44%	124.6%
Operating Expenses	$7.007M	$4.860M	$5.228M
YoY Change	72.25%	19.26%	41.83%
Operating Profit	$208.0K	-$717.0K	-$6.637M
YoY Change	-101.96%	-93.54%	-45.96%
Interest Expense	-$8.098M	-$8.232M	-$4.675M
YoY Change	112.43%	118.18%	26.04%
% of Operating Profit	-3893.27%
Other Income/Expense, Net
YoY Change
Pretax Income	-$7.890M	-$592.0K	-$59.52M
YoY Change	84.22%	-96.02%	272.18%
Income Tax	-$696.0K	$2.199M	-$720.0K
% Of Pretax Income
Net Earnings	-$7.194M	-$2.791M	-$58.80M
YoY Change	67.22%	-81.27%	266.9%
Net Earnings / Revenue	-14.64%	-6.6%	-168.03%
Basic Earnings Per Share	-$0.53	-$0.21	-$5.20
Diluted Earnings Per Share	-$0.53	-$0.21	-$5.20
COMMON SHARES
Basic Shares Outstanding	13.62M	13.59M	11.30M
Diluted Shares Outstanding	13.59M	13.59M	11.30M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.566M	$7.294M	$9.342M
YoY Change	75.87%	20.92%	73.0%
Cash & Equivalents	$7.566M	$7.294M	$9.342M
Short-Term Investments
Other Short-Term Assets	$102.0K	$77.00K	$9.000K
YoY Change	5000.0%	3750.0%	-99.8%
Inventory	$1.433M	$1.377M	$1.301M
Prepaid Expenses
Receivables	$33.97M	$26.82M	$24.23M
Other Receivables	$0.00	$191.0K	$0.00
Total Short-Term Assets	$45.91M	$37.90M	$39.42M
YoY Change	82.65%	58.0%	85.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$365.2M	$357.8M	$360.0M
YoY Change	-0.35%	-3.43%	-4.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.159M	$2.115M	$2.201M
YoY Change	-20.71%	-29.64%	-32.71%
Total Long-Term Assets	$367.3M	$358.7M	$361.0M
YoY Change	-0.06%	-3.52%	-4.26%
TOTAL ASSETS
Total Short-Term Assets	$45.91M	$37.90M	$39.42M
Total Long-Term Assets	$367.3M	$358.7M	$361.0M
Total Assets	$413.2M	$396.5M	$400.4M
YoY Change	5.23%	0.21%	0.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$28.86M	$17.07M	$18.83M
YoY Change	117.56%	66.57%	289.27%
Accrued Expenses	$13.16M	$9.044M	$10.55M
YoY Change	3.05%	-16.72%	11.33%
Deferred Revenue	$1.227M	$250.0K	$1.701M
YoY Change	149.9%	-49.6%	717.79%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.302M	$3.225M	$3.902M
YoY Change		-67.75%	-67.75%
Total Short-Term Liabilities	$45.45M	$36.27M	$33.28M
YoY Change	39.19%	-3.65%	26.04%
LONG-TERM LIABILITIES
Long-Term Debt	$136.8M	$122.1M	$120.1M
YoY Change	-0.56%	-8.77%	-9.7%
Other Long-Term Liabilities	$1.661M	$1.977M	$1.894M
YoY Change	-40.89%	-27.66%	-28.66%
Total Long-Term Liabilities	$1.661M	$1.977M	$1.894M
YoY Change	-40.89%	-27.66%	-28.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$45.45M	$36.27M	$33.28M
Total Long-Term Liabilities	$1.661M	$1.977M	$1.894M
Total Liabilities	$203.3M	$180.6M	$251.2M
YoY Change	17.1%	3.31%	51.81%
SHAREHOLDERS EQUITY
Retained Earnings	-$402.6M	-$395.4M	-$392.6M
YoY Change	33.17%	32.68%	38.67%
Common Stock	$616.5M	$615.3M	$545.7M
YoY Change	17.35%	17.68%	4.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)			$3.923M
YoY Change			0.26%
Treasury Stock Shares			$81.85K
Shareholders Equity	$210.0M	$216.0M	$149.2M
YoY Change
Total Liabilities & Shareholders Equity	$413.2M	$396.5M	$400.4M
YoY Change	5.23%	0.21%	0.52%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$7.194M	-$2.791M	-$58.80M
YoY Change	67.22%	-81.27%	266.9%
Depreciation, Depletion And Amortization	$10.12M	$9.848M	$9.751M
YoY Change	3.91%	3.5%	-2.39%
Cash From Operating Activities	$11.73M	$4.124M	-$1.661M
YoY Change	-514.04%	190.22%	-73.59%
INVESTING ACTIVITIES
Capital Expenditures	-$10.16M	-$5.846M	$6.279M
YoY Change	88.27%	128.81%	260.45%
Acquisitions
YoY Change
Other Investing Activities	$767.0K	$1.393M	$589.0K
YoY Change	-30.9%	1465.17%	-9.38%
Cash From Investing Activities	-$9.394M	-$4.453M	-$5.690M
YoY Change	119.13%	80.58%	422.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.068M	-1.719M	12.55M
YoY Change	-138.36%	-204.95%	2228.94%
NET CHANGE
Cash From Operating Activities	11.73M	4.124M	-1.661M
Cash From Investing Activities	-9.394M	-4.453M	-5.690M
Cash From Financing Activities	-2.068M	-1.719M	12.55M
Net Change In Cash	272.0K	-2.048M	5.202M
YoY Change	-115.72%	-445.36%	-176.06%
FREE CASH FLOW
Cash From Operating Activities	$11.73M	$4.124M	-$1.661M
Capital Expenditures	-$10.16M	-$5.846M	$6.279M
Free Cash Flow	$21.89M	$9.970M	-$7.940M
YoY Change	754.27%	150.75%	-1.15%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13590000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6714000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12453000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6466000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2021Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
	dei	Entity Central Index Key EntityCentralIndexKey	0001537028
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q1	icd	Fair Value Liabilities Level Transfers Amount FairValueLiabilitiesLevelTransfersAmount	0
CY2022Q2	icd	Fair Value Liabilities Level Transfers Amount FairValueLiabilitiesLevelTransfersAmount	0
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.95
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.78
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3360000
CY2022Q1	icd	Stock Issued During Period Value Restructuring StockIssuedDuringPeriodValueRestructuring	9163000
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22211000
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1377000
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P6M
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q2	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2022Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations
CY2022Q2	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligations http://fasb.org/us-gaap/2022#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2020Q2	icd	Debt Instrument Accrued And Unpaid Interest Only Payment Period DebtInstrumentAccruedAndUnpaidInterestOnlyPaymentPeriod	P3M
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.95
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.78
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36590
	dei	Entity Registrant Name EntityRegistrantName	Independence Contract Drilling, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1653648
	dei	Entity Address Address Line1 EntityAddressAddressLine1	20475 State Highway 249
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
	dei	Entity Address City Or Town EntityAddressCityOrTown	Houston
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	77070
	dei	City Area Code CityAreaCode	281
	dei	Local Phone Number LocalPhoneNumber	598-1230
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value per share
	dei	Trading Symbol TradingSymbol	ICD
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13617005
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7294000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4140000
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	26820000
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1171000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2406000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4787000
CY2022Q2	us-gaap	Assets Current AssetsCurrent	37897000
CY2021Q4	us-gaap	Assets Current AssetsCurrent	32309000
CY2022Q2	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	356537000
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	362346000
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	17065000
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2115000
CY2021Q4	us-gaap	Assets Assets	397104000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	3225000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	4464000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	141740000
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	20225000
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2449000
CY2022Q2	us-gaap	Assets Assets	396549000
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	15304000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9044000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11245000
CY2022Q2	us-gaap	Interest Payable Current InterestPayableCurrent	6939000
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4372000
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2902000
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	36273000
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	38287000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	122094000
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	19037000
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1977000
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2811000
CY2022Q2	us-gaap	Liabilities Liabilities	180569000
CY2021Q4	us-gaap	Liabilities Liabilities	201875000
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13698851
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10287931
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13617005
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10206085
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	136000
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	102000
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	615130000
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	532826000
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-395363000
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-333776000
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	81846
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	81846
CY2022Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3923000
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	3923000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	215980000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	195229000
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	396549000
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	397104000
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42313000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19817000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	77304000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35359000
CY2022Q2	us-gaap	Direct Operating Costs DirectOperatingCosts	28904000
CY2021Q2	us-gaap	Direct Operating Costs DirectOperatingCosts	17040000
	us-gaap	Direct Operating Costs DirectOperatingCosts	56069000
	us-gaap	Direct Operating Costs DirectOperatingCosts	31581000
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4860000
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1098000
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	404000
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4075000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	10088000
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9848000
CY2022Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	582000
CY2021Q2	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-31000
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7761000
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9516000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19599000
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19505000
CY2021Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	250000
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	293000
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	43030000
CY2021Q2	us-gaap	Costs And Expenses CostsAndExpenses	30912000
	us-gaap	Costs And Expenses CostsAndExpenses	84658000
	us-gaap	Costs And Expenses CostsAndExpenses	58736000
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-717000
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11095000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7354000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-23377000
CY2022Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-8232000
CY2021Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3773000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-12907000
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-7482000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46347000
CY2022Q2	icd	Change In Fair Value Of Embedded Derivative Liability ChangeInFairValueOfEmbeddedDerivativeLiability	2408000
	icd	Change In Fair Value Of Embedded Derivative Liability ChangeInFairValueOfEmbeddedDerivativeLiability	4265000
CY2022Q2	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10765000
	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10765000
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-592000
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14868000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-60108000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-30859000
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2199000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	33000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1479000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	67000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2791000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14901000
	us-gaap	Net Income Loss NetIncomeLoss	-61587000
	us-gaap	Net Income Loss NetIncomeLoss	-30926000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.95
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.78
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13590000
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6714000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12453000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6466000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	195229000
CY2022Q1	icd	Stock Issued During Period Value Restricted Stock Units Vested Net Of Shares Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockUnitsVestedNetOfSharesWithheldForTaxes	32000
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	292000
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-58796000
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	521000
CY2021Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	874000
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	149216000
CY2022Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-205000
CY2022Q2	icd	Adjustments To Additional Paid In Capital Extinguishment Of Derivative AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfDerivative	69232000
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	528000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2791000
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	215980000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	247033000
CY2021Q1	icd	Stock Issued During Period Value Restricted Stock Units Vested Net Of Shares Withheld For Taxes StockIssuedDuringPeriodValueRestrictedStockUnitsVestedNetOfSharesWithheldForTaxes	11000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	454000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-16025000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	232846000
CY2021Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1472000
CY2021Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1075000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	454000
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14901000
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	220946000
	us-gaap	Profit Loss ProfitLoss	-61587000
	us-gaap	Profit Loss ProfitLoss	-30926000
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	19599000
	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	19505000
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	293000
	us-gaap	Share Based Compensation ShareBasedCompensation	1203000
	us-gaap	Share Based Compensation ShareBasedCompensation	1217000
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	1098000
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	404000
	us-gaap	Paid In Kind Interest PaidInKindInterest	3193000
	us-gaap	Paid In Kind Interest PaidInKindInterest	2828000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-46347000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	285000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	558000
	icd	Amortization Of Convertible Notes Issuance Costs And Debt Discount AmortizationOfConvertibleNotesIssuanceCostsAndDebtDiscount	2350000
	icd	Change In Fair Value Of Embedded Derivative Liability ChangeInFairValueOfEmbeddedDerivativeLiability	4265000
	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10765000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1479000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	67000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4609000
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4039000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	206000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	39000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2516000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2209000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-509000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	3862000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2463000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4869000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12125000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10143000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3556000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4295000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1982000
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	739000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2178000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3154000
	icd	Payments Of Merger Consideration PaymentsOfMergerConsideration	2902000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	32000
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	11000
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	7057000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2278000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1754000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10834000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6247000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4140000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12279000
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7294000
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6032000
	us-gaap	Interest Paid Net InterestPaidNet	4493000
	us-gaap	Interest Paid Net InterestPaidNet	3406000
	icd	Purchases Of Property Plant And Equipment In Accounts Payable PurchasesOfPropertyPlantAndEquipmentInAccountsPayable	1130000
	icd	Purchases Of Property Plant And Equipment In Accounts Payable PurchasesOfPropertyPlantAndEquipmentInAccountsPayable	2171000
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1367000
	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	632000
	icd	Finance Lease Extinguishment Of Lease Obligations From Sale Of Assets FinanceLeaseExtinguishmentOfLeaseObligationsFromSaleOfAssets	77000
	us-gaap	Transfer Of Portfolio Loans And Leases To Held For Sale1 TransferOfPortfolioLoansAndLeasesToHeldForSale1	550000
	icd	Non Cash Or Part Non Cash Expenses Restructuring Fees NonCashOrPartNonCashExpensesRestructuringFees	9163000
CY2022Q1	icd	Market Price Of Oil MarketPriceOfOil	123.64
CY2022Q3	icd	Natural Gas Price NaturalGasPrice	9.46
CY2022Q2	icd	Number Of Rigs Operating And Under Construction NumberOfRigsOperatingAndUnderConstruction	17
CY2022Q2	icd	Number Of Contracts Signed To Convert Rigs NumberOfContractsSignedToConvertRigs	2
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	2400000
CY2022Q2	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	69200000
CY2022Q2	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10800000
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	42313000
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19817000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	77304000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	35359000
CY2022Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0
CY2022Q2	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	26800000
CY2021Q4	us-gaap	Contract With Customer Receivable After Allowance For Credit Loss ContractWithCustomerReceivableAfterAllowanceForCreditLoss	22167000
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	250000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	542000
CY2022Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1544000
CY2021Q2	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	208000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	540000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	119000
CY2022Q2	icd	Contract With Customer Liability Increase Decrease From Cash Receipts ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts	93000
CY2021Q2	icd	Contract With Customer Liability Increase Decrease From Cash Receipts ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts	288000
	icd	Contract With Customer Liability Increase Decrease From Cash Receipts ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts	248000
	icd	Contract With Customer Liability Increase Decrease From Cash Receipts ContractWithCustomerLiabilityIncreaseDecreaseFromCashReceipts	496000
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	245000
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	5000
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	0
CY2022Q2	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	100000
CY2021Q4	us-gaap	Capitalized Contract Cost Net Current CapitalizedContractCostNetCurrent	600000
CY2022Q2	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	100000
	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	2100000
CY2022Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1400000
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2600000
CY2021Q2	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	700000
	icd	Capitalized Contract Cost Increase CapitalizedContractCostIncrease	1200000
CY2021Q2	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	400000
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	800000
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	193000
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	234000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	387000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	469000
CY2022Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1268000
CY2021Q2	us-gaap	Short Term Lease Cost ShortTermLeaseCost	660000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	2665000
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1222000
CY2022Q2	us-gaap	Variable Lease Cost VariableLeaseCost	133000
CY2021Q2	us-gaap	Variable Lease Cost VariableLeaseCost	102000
	us-gaap	Variable Lease Cost VariableLeaseCost	256000
	us-gaap	Variable Lease Cost VariableLeaseCost	199000
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	330000
CY2021Q2	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	286000
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	645000
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	545000
CY2022Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	99000
CY2021Q2	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	155000
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	213000
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	321000
CY2022Q2	icd	Finance Lease Cost FinanceLeaseCost	429000
CY2021Q2	icd	Finance Lease Cost FinanceLeaseCost	441000
	icd	Finance Lease Cost FinanceLeaseCost	858000
	icd	Finance Lease Cost FinanceLeaseCost	866000
CY2022Q2	us-gaap	Lease Cost LeaseCost	2023000
CY2021Q2	us-gaap	Lease Cost LeaseCost	1437000
	us-gaap	Lease Cost LeaseCost	4166000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	733000
	us-gaap	Lease Cost LeaseCost	2756000
	us-gaap	Operating Lease Payments OperatingLeasePayments	364000
	us-gaap	Operating Lease Payments OperatingLeasePayments	487000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	211000
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	317000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2278000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1754000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	153000
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1367000
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	632000
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1267000
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1437000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	693000
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	759000
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1036000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1492000
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1729000
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	15978000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	14989000
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	2328000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	1989000
CY2022Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	13650000
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	13000000
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3225000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4464000
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1559000
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1305000
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	4784000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	5769000
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M18D
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1068
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1084
CY2022Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0820
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0864
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	438000
CY2022Q2	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	2829000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	833000
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	1521000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	390000
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	523000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	0
CY2022Q2	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	177000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1661000
CY2022Q2	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	5050000
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	169000
CY2022Q2	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	266000
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	1492000
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	4784000
	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-1900000
CY2022Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	2400000
CY2022Q2	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	69200000
CY2022Q2	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10800000
CY2022Q1	icd	Fair Value Assets Level Transfers Amount FairValueAssetsLevelTransfersAmount	0
CY2022Q2	icd	Fair Value Assets Level Transfers Amount FairValueAssetsLevelTransfersAmount	0
	us-gaap	Debt Instrument Term DebtInstrumentTerm	P3Y8M12D
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2022Q2	us-gaap	Prepaid Insurance PrepaidInsurance	1292000
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3463000
CY2022Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	705000
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	575000
CY2022Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	141000
CY2021Q4	us-gaap	Deferred Costs Current DeferredCostsCurrent	618000
CY2022Q2	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	191000
CY2021Q4	us-gaap	Insurance Settlements Receivable Current InsuranceSettlementsReceivableCurrent	122000
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	77000
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	9000
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2406000
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4787000
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3988000
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4154000
CY2022Q2	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	736000
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	2523000
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	250000
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	542000
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2306000
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2594000
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	733000
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	693000
CY2022Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1031000
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	739000
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	9044000
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11245000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	27867
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	4784000
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	5769000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	170108000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	147952000
CY2022Q2	icd	Convertible Notes Issuance Costs And Debt Discount ConvertibleNotesIssuanceCostsAndDebtDiscount	44789000
CY2021Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	1748000
CY2022Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3225000
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4464000
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	122094000
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	141740000
CY2022Q2	us-gaap	Embedded Derivative Gain Loss On Embedded Derivative Net EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet	2400000
CY2022Q2	us-gaap	Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity	69200000
CY2022Q2	icd	Realized Gain On Extinguishment Of Derivative RealizedGainOnExtinguishmentOfDerivative	10800000
CY2020Q2	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0075
CY2020Q2	icd	Debt Instrument Direct Reduction From Face Amount DebtInstrumentDirectReductionFromFaceAmount	1000000.0
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	472000
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	680000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1203000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1217000
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
CY2021Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
CY2022Q2	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-14901000
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	27867
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	254.80
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	254.80
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Shares Outstanding SharesOutstanding	13617005
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	81846
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2791000
	us-gaap	Net Income Loss NetIncomeLoss	-61587000
	us-gaap	Net Income Loss NetIncomeLoss	-30926000
CY2022Q1	icd	Number Of Additional Representative To Be Appointed As Individual Director NumberOfAdditionalRepresentativeToBeAppointedAsIndividualDirector	1
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.95
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.78
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13590000
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6714000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12453000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6466000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13590000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6714000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	12453000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6466000
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-3.715
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.025
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.002
CY2022Q2	us-gaap	Purchase Obligation PurchaseObligation	3900000
CY2022Q1	icd	Investor S Rights Agreement Number Of Directors Who Can Be Nominated InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated	1
CY2022Q1	icd	Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector	2
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	78900000
CY2022Q1	icd	Investor S Rights Agreement Number Of Directors Who Can Be Nominated InvestorSRightsAgreementNumberOfDirectorsWhoCanBeNominated	1
CY2022Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	25000000.0
CY2022Q1	icd	Number Of Holder Representatives That Have Right To Nominate Additional Representative As Director NumberOfHolderRepresentativesThatHaveRightToNominateAdditionalRepresentativeAsDirector	2
CY2022Q1	icd	Number Of Directors NumberOfDirectors	6
CY2022Q3	icd	Number Of Directors NumberOfDirectors	7

Files In Submission

Name	View Source	Status
0001537028-22-000043-index-headers.html	Edgar Link	pending
0001537028-22-000043-index.html	Edgar Link	pending
0001537028-22-000043.txt	Edgar Link	pending
0001537028-22-000043-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
icd-20220630.xsd	Edgar Link	pending
icd-20220630x10q.htm	Edgar Link	pending
icd-20220630x10q_htm.xml	Edgar Link	completed
icd-20220630xex31d1.htm	Edgar Link	pending
icd-20220630xex31d2.htm	Edgar Link	pending
icd-20220630xex32d1.htm	Edgar Link	pending
icd-20220630xex32d2.htm	Edgar Link	pending
icd-20220630_cal.xml	Edgar Link	unprocessable
icd-20220630_def.xml	Edgar Link	unprocessable
icd-20220630_lab.xml	Edgar Link	unprocessable
icd-20220630_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq

2022 Q3 Form 10-Q Financial Statement

#000153702822000043 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICDIQ Independence Contract Drilling, Inc. Stock $icdiq

2022 Q3 Form 10-Q Financial Statement

#000153702822000043 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ICDIQ
Independence Contract Drilling, Inc. Stock $icdiq